This is an exceptionally good result for a diagnostic test
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The Sahlgrenska Academy have now developed a method which identifies the cancer’s visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
The poor prognosis for pancreatic cancer, where only 5 percent of the patients survive five years after the diagnosis, is due to the fact that the tumors often develop unnoticed, and rarely cause symptoms until they have spread to other organs.
Recent studies, however, have shown that fluid-filled compartments in the pancreas, called cysts, may be precursors of the cancer.
Hard to identify harmful cysts
Cysts in the pancreas, which are found in every 10th person above the age of 70, and are also common in younger people, can be discovered with computed tomography (CT) or magnetic resonance imaging (MRI).
The problem is that imaging alone cannot determine which cysts are at risk for developing into cancer. Therefore, it often becomes necessary to puncture the cyst and look for tumor markers in the cyst fluid but not even these analyses are reliable.
Removing the cyst by surgery, with the knowledge that it may turn out to be completely benign, is also problematic since the operation is extensive, with considerable risks for the patient.
97 percent certainty
Researchers at The Sahlgrenska Academy, University of Gothenburg, have now developed a method which can predict with 97 percent certainty which pancreatic cysts constitute precursors to cancer. With this method, which detects the presence of mucus protein, mucins, in the cystic fluid, the researchers were able to reach the correct diagnosis in 77 of 79 cysts that were examined.
– This is an exceptionally good result for a diagnostic test, and we are very hopeful that the method will enable more instances of early discovery of pancreatic cancer, at a stage when the cancer can be treated or prevented. This approach may also minimize the risk of unnecessary operations on non-malignant cysts, said Karolina Jabbar, PhD student at The Sahlgrenska Academy and physician at The Sahlgrenska University Hospital.
Helps operation decisions
The researchers have also tested the new method in order to analyze existing tumors and, with about 90 percent certainty, have been able to determine which tumors have already developed into cancers. This means that the method could also be used to determine which patients require immediate surgery, and when it is instead possible to wait and monitor the development of the cyst.
The method which has been used in the study is called proteomics, which means the analysis of the protein content of a tissue or fluid with the help of mass spectrometry . This method has thus far been used in research. But Professor Gunnar C. Hansson who, together with senior physician and Assistant Professor Riadh Sadik, initiated the study, is convinced that the proteomics will soon be introduced in health care.
– The technique has been developed, and we can now measure biomarkers both quickly and exactly. Moreover, the method requires minimal biomaterial, in this case 25 times less cyst fluid than conventional tumor marker analyses. I am certain that within five years the mass spectrometers will have moved into the hospital corridors, he said.
The Latest on: Pancreatic Cancer
via Google News
The Latest on: Pancreatic Cancer
- Creative Biolabs Provides Abundant Recombinant Antibody Products Targeting at the Pancreatic Canceron September 6, 2019 at 3:55 pm
Pancreatic cancer, ranking third in cancer-related deaths in the United States, has been taken as one of the malignant tumors of the digestive system, marked with strong invasiveness, high degree of ...
- Harvard Study Say Cannabis May Help Fight Pancreatic Canceron September 6, 2019 at 5:19 am
Scientific evidence is beginning to mount that cannabis may prove beneficial in the fight against cancer. The latest comes from a Harvard University study involving cannabis flavonoids and pancreatic ...
- New medicine may enhance the effect of chemotherapy on pancreatic canceron September 5, 2019 at 5:08 am
One of the major obstacles in the treatment of pancreatic cancer is the defense wall that is formed around the tumor. This "desmoplastic stroma" prevents chemotherapy from reaching the tumor.
- Health watch: A new way to treat pancreatic canceron September 4, 2019 at 10:06 pm
Over the past few years, there's been increased awareness of pancreatic cancer with the deaths of actor Patrick Swayze, and Apple co-founder Steve Jobs. Right now, jeopardy host Alex Trebek is ...
- Here's Why Pancreatic Cancer Is Hard To Treaton September 4, 2019 at 9:57 pm
As one of the most deadly cancers plaguing us today, it’s unfortunate that pancreatic cancer is still nearly impossible to treat or cure. In a world where chemotherapy and other forms of treatment are ...
- Study confirms protein as potential cause of most common type of pancreatic canceron September 4, 2019 at 2:01 pm
Researchers at The University of Texas MD Anderson Cancer Center have confirmed a protein as an oncogene responsible for the most common and lethal form of pancreatic cancer known as pancreatic ...
- Did a 15-Year-Old Invent a ‘100% Accurate’ Pancreatic Cancer Test?on September 4, 2019 at 9:18 am
Jack Andraka, 15, came up with a “100 percent accurate” cancer-detection method that was “168 times faster, 26,000 times less expensive, and 400 times more sensitive” than current methods. Though his ...
- Drug developed to treat metastatic pancreatic cancer may help prolong lifeon September 4, 2019 at 6:00 am
A drug developed by researchers at the Renaissance School of Medicine at Stony Brook University that targets enzymes involved in the development of pancreatic cancer cells is showing promise for ...
- Pancreatic cancer tumors attack the blood vessels that deliver chemo drugson September 4, 2019 at 4:12 am
Pancreatic cancer is nearly impossible to treat. New research now shows this may be because its tumors destroy the surrounding blood vessels that doctors typically rely on to deliver anti-cancer drugs ...
- Pancreatic Cancer Action Network Appoints Columbia Sportswear Executive Lisa Kulok To Board Of Directorson September 4, 2019 at 3:00 am
MANHATTAN BEACH, Calif., Sept. 4, 2019 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading patient advocacy organization, announced today that Columbia Sportswear executive Lisa ...
via Bing News